EUVIMEDEUVIMED entdecken
Crossref

MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy

Jianyu Zhao, Zewen Sun, Zimeng Li, Mengyu Xu, Aowen Tian, Zhengwen An, Wenbo Guo, Chang He iD, Ying Dong, Jianping Wen, Jianli Yang, Qing Wang iD und 1 weitere

Diabetes, Obesity and Metabolism · 2025-04 · 27 (4) · 1888-1901

DOI: 10.1111/dom.16182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 07.01.2025. Verfasst von Jianyu Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Proto-Oncogene Protein c-ets-1, Diabetic Retinopathy, MicroRNAs, Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province, Diabetes Fund of the Chinese Microcirculation Society Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to discover the regulatory mechanisms contributing to angiogenesis in nonproliferative diabetic retinopathy (NPDR). Materials and Methods This study employed a case–control design involving type 2 diabetes patients with and without NPDR. We utilised microRNA sequencing to analyse plasma and retina samples from T2D patients, to identify both existing and novel microRNAs relevant to retinal health. An integrative approach combining single‐cell sequencing data from mouse and rat models was used to explore the molecular mechanism in retinal cells under diabetes condition.

Results

We identified a specific set of circulating microRNAs with strong predictive potential for distinguishing NPDR patients. In addition, a novel microRNA targeting the ETS proto‐oncogene 1 (Ets1), a key regulator of microvascular angiogenesis, was found to be upregulated in the plasma of NPDR patients. Analysis of single‐cell sequencing data suggested that Ets1 expression was downregulated in diabetic endothelial cells and was associated with the repression of Angiopoietin‐1 and phosphoinositide 3‐kinase‐Akt (PI3K‐Akt) signalling pathways, indicating an anti‐angiogenic mechanism in NPDR.

Conclusions

The identification of a novel microRNA involved in the anti‐angiogenic mechanism in NPDR provides new insights into the molecular underpinnings of endothelial dysfunction in diabetic retinopathy. Our retina‐specific circulating microRNA panel has potential utility in risk assessment and early detection of NPDR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Protein c-ets-1Diabetic RetinopathyMicroRNAsEndothelial CellsDiabetes Mellitus, Type 2RetinaHumansAnimalsMaleRatsMiceCase-Control StudiesProto-Oncogene MasMiddle AgedFemaleSignal TransductionDown-RegulationAngiopoietin-1

Stichwörter der Autor:innen

Ets1angiogenesisangiopoietindiabetic retinopathymicroRNA

Substanzen

Proto-Oncogene Protein c-ets-1MicroRNAsETS1 protein, humanMAS1 protein, humanProto-Oncogene MasAngiopoietin-1

Autor:innen und Institutionen

  • Department of Endocrinology, China-Japan Union Hospital, Jilin University, Changchun, China.
  • Department of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, China.
  • Department of Oral Biology, School and Hospital of Stomatology, Jilin University, Changchun, China.
  • Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, School and Hospital of Stomatology, Jilin University, Changchun, China.
  • Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun, China.
  • Department of Pathology, College of Basic Medical Sciences, Jilin University, Changchun, China.

ORCID-Profile: Chang He, Qing Wang, Peng Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jilin Province
  • Diabetes Fund of the Chinese Microcirculation Society Major Project
  • Jilin Provence Budgeted Basic Construction Funds
  • ChangBai Mountain Scholars Program of Jilin Province

Zitieren

APA

Zhao, J., Sun, Z., Li, Z., Xu, M., Tian, A., An, Z., Guo, W., He, C., Dong, Y., Wen, J., Yang, J., Wang, Q., & Chen, P. (2025). MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy. Diabetes, Obesity and Metabolism, 27(4), 1888-1901. https://doi.org/10.1111/dom.16182

Vancouver

Zhao J, Sun Z, Li Z, Xu M, Tian A, An Z, et al. MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy. Diabetes, Obesity and Metabolism. 2025;27(4):1888-1901. doi:10.1111/dom.16182

BibTeX
@article{Zhao2025,
  author = {Zhao, Jianyu and Sun, Zewen and Li, Zimeng and Xu, Mengyu and Tian, Aowen and An, Zhengwen and Guo, Wenbo and He, Chang and Dong, Ying and Wen, Jianping and Yang, Jianli and Wang, Qing and Chen, Peng},
  title = {MicroRNA ‐mediated Ets1 repression in retinal endothelial cells: A novel anti‐angiogenic mechanism in nonproliferative diabetic retinopathy},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {4},
  pages = {1888--1901},
  doi = {10.1111/dom.16182}
}
Kostenlos starten →